Since 1995, Reliable Business Intelligence for Clinical Laboratories, Pathology Groups and Laboratory Diagnostics

Subscriber?
Search

TDR Insider

What’s Behind the Surge in Laboratory Outreach Sales?

TDR Insider /

The recent CHS-Labcorp deal is one of many that highlights a market shift. Clinical lab outreach services, once viewed as strategic assets, are being sold off rapidly as hospitals recenter around core services and offload logistical burdens. This year, 30% of lab mergers and acquisitions involve outreach agreements, with national lab companies seeing opportunities to […]

To access this post, you must purchase The Dark Report.

What’s Behind the Surge in Laboratory Outreach Sales? Read More »

Clinical Laboratories Battle Complex Claims Denials

TDR Insider /

While the number of denials is not going up, the reasons that private payers deny claims are becoming more complex and time-consuming to appeal. After reviewing noteworthy trends among payers, learn a three-level approach to appeals that may lead to greater success and speed up the process. “The good news is that the volume of

To access this post, you must purchase The Dark Report.

Clinical Laboratories Battle Complex Claims Denials Read More »

Lab Stakeholders Discuss PAMA Reforms

TDR Insider /

Medical labs need to brace for more action to counter pending test reimbursement rate cuts under PAMA. Although labs have received PAMA reprieves from Congress over the last few years, laboratory associations argue that Congress needs to vote on long-term reforms rather than stop-gap measures. Labs scored one victory when the Trump administration declined to

To access this post, you must purchase The Dark Report.

Lab Stakeholders Discuss PAMA Reforms Read More »

Workers Use AI More than Lab Leaders Do

TDR Insider /

In part one of an analysis about the state of AI in clinical laboratories, The Dark Report explores how frontline workers, especially younger ones, are using AI tools like ChatGPT far more than lab leaders. Recent reports elsewhere in the business world show executives underestimate staff AI use, raising concerns about a leadership gap in

To access this post, you must purchase The Dark Report.

Workers Use AI More than Lab Leaders Do Read More »

Leveraging Data to Create Lab and Healthcare Efficiencies

TDR Insider /

In this exclusive interview with The Dark Report, Bradley Bostic, founder, chair, and CEO of healthcare and laboratory data intelligence company hc1 discusses trends in healthcare, how to position clinical laboratories as a strategic asset, and ways to analyze diagnostic data to improve efficiency and increase the bottom line. A key point Bostic reiterates: Third-party

To access this post, you must purchase The Dark Report.

Leveraging Data to Create Lab and Healthcare Efficiencies Read More »

Economic and Tech Changes Drive Lab Concerns

TDR Insider /

CEO SUMMARY: Uncertainty around tariffs, future regulations, and artificial intelligence (AI) defined the mood at the 2025 Executive War College, where nearly 1,000 lab leaders gathered. Speakers warned of how stagnant healthcare spending could trickle down to labs. Meanwhile, attendees considered potential tariff impacts on their lab supplies and how to navigate the threat of

To access this post, you must purchase The Dark Report.

Economic and Tech Changes Drive Lab Concerns Read More »

With LDT Rule Vacated, Labs Await FDA Response

TDR Insider /

In a major win for clinical laboratories, a federal judge vacated the FDA’s final rule on LDTs, writing in his decision that the agency overstepped its authority. For now, labs can develop and modify LDTs without FDA oversight, but future action in some form is likely. In part one of our report about the decision,

To access this post, you must purchase The Dark Report.

With LDT Rule Vacated, Labs Await FDA Response Read More »

The Role of Price Transparency During Pathology Contract Talks

TDR Insider /

Pathology groups have a much better opportunity to turn the tables on payers and other third parties during contract negotiations if they come armed with the data and other information recommended by two well-respected pathology experts. In this final installment of our four-part series, the price transparency approach is explained. Also discussed is the importance

To access this post, you must purchase The Dark Report.

The Role of Price Transparency During Pathology Contract Talks Read More »

Medical Robotics Developer Believes It’s Time to Transform Phlebotomy

TDR Insider /

Phlebotomy and collection of veinous blood is one important procedure in clinical laboratory testing that continues to be primarily a manual process. That is about to change. Netherlands-based Vitestro has obtained a CE mark in the European Union for its novel autonomous robotic phlebotomy device (ARPD), which is already in operation in a hospital in

To access this post, you must purchase The Dark Report.

Medical Robotics Developer Believes It’s Time to Transform Phlebotomy Read More »

Why Labs Should Comply with the FDA’s Final Rule on LDTs

TDR Insider /

On April 29, 2024, the Food and Drug Administration released its final rule on regulation of laboratory developed tests (LDTs). Since then, clinical laboratories have grappled with questions surrounding compliance, while hoping that courts will step in and prevent the rule from taking effect. Now, with a new administration in power and what seem to

To access this post, you must purchase The Dark Report.

Why Labs Should Comply with the FDA’s Final Rule on LDTs Read More »

;